Barclays PLC Repare Therapeutics Inc. Transaction History
Barclays PLC
- $436 Billion
- Q2 2025
A detailed history of Barclays PLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Barclays PLC holds 530 shares of RPTX stock, worth $996. This represents 0.0% of its overall portfolio holdings.
Number of Shares
530
Previous 530
-0.0%
Holding current value
$996
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RPTX
# of Institutions
56Shares Held
30.8MCall Options Held
163KPut Options Held
0-
Bvf Inc San Francisco, CA10.3MShares$19.4 Million0.56% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$6.47 Million2.59% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$6.25 Million0.16% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$5.58 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$4.98 Million6.53% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $78.8M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...